126 related articles for article (PubMed ID: 3922501)
21. Delta agent infection in Melbourne.
Hoy JF; Hansson BG; Dimitrakakis M; Gust I; Lucas CR
J Med Virol; 1984; 13(4):339-45. PubMed ID: 6736942
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of delta virus infection in Thai intravenous drug abusers.
Louisirirotchanakul S; Wasi C; Uneklabh C; Phutiprawan T; Suwanagool S; Chainuvati T; Thongcharoen P
Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):191-5. PubMed ID: 3227398
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.
Novick DM; Farci P; Croxson TS; Taylor MB; Schneebaum CW; Lai ME; Bach N; Senie RT; Gelb AM; Kreek MJ
J Infect Dis; 1988 Oct; 158(4):795-803. PubMed ID: 3171227
[TBL] [Abstract][Full Text] [Related]
24. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
[TBL] [Abstract][Full Text] [Related]
25. Course of hepatitis delta virus infection in auxiliary liver grafts in patients with delta virus cirrhosis.
ten Kate FJ; Schalm SW
Prog Clin Biol Res; 1991; 364():429-37. PubMed ID: 2020719
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of hepatitis B virus and delta agent in parenteral drug abusers. Immunogenicity of hepatitis B vaccine.
Kunches LM; Craven DE; Werner BG
Am J Med; 1986 Oct; 81(4):591-5. PubMed ID: 3766588
[TBL] [Abstract][Full Text] [Related]
27. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
[TBL] [Abstract][Full Text] [Related]
28. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
29. Influence of delta infection on severity of hepatitis B.
Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
[TBL] [Abstract][Full Text] [Related]
30. [Changes in the response time of anti-HBc IgM in a hepatitis B case load. Diagnostic implications].
Cremoni L; Buffa D; Sauco F; Bongetta R; Arosio M; d'Amico P
Boll Ist Sieroter Milan; 1986; 65(5):430-5. PubMed ID: 3828097
[TBL] [Abstract][Full Text] [Related]
31. Delta virus infections in and around Chandigarh, northern India: evidence for endemicity.
Pal SR; Prasad SR
Trop Geogr Med; 1987 Apr; 39(2):123-5. PubMed ID: 3629703
[TBL] [Abstract][Full Text] [Related]
32. Significance of liver histology in HBsAg-positive, IgM anti-HBc-negative acute hepatitis B virus-related hepatitis.
Delladetsima I; Papatheodoridis GV; Tiniakos DG; Hatzakis A; Tassopoulos NC
Histopathology; 2012 Nov; 61(5):881-8. PubMed ID: 22882633
[TBL] [Abstract][Full Text] [Related]
33. Acute delta hepatitis without circulating HBsAg.
De Cock KM; Govindarajan S; Redeker AG
Gut; 1985 Feb; 26(2):212-4. PubMed ID: 3967840
[TBL] [Abstract][Full Text] [Related]
34. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
35. [Hepatitis B and hepatitis delta in young inmates].
Bayas JM; Bruguera M; Martín V; Mayor A; de la Fuente ML; Laliga A; Salleras L
Med Clin (Barc); 1990 Feb; 94(5):164-8. PubMed ID: 2325476
[TBL] [Abstract][Full Text] [Related]
36. [Quantitative and qualitative findings of hepatitis B virus-associated antigens, receptors and antibodies in the course of the acute phase of hepatitis B infection].
Gröticke JW; Gerken G; Steinmann J; Arnold W
Z Gastroenterol; 1988 Jul; 26(7):363-73. PubMed ID: 2851892
[TBL] [Abstract][Full Text] [Related]
37. High titre of antibody to hepatitis B core antigen detected by immune adherence haemagglutination in HBsAg-positive acute hepatitis.
Ikegami F; Takasu S; Jo K; Miyakawa Y; Tsuda F; Mayumi M
Hepatogastroenterology; 1982 Aug; 29(4):142-3. PubMed ID: 7129336
[TBL] [Abstract][Full Text] [Related]
38. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
39. Pathobiology of hepatitis B virus.
Gerber MA; Thung SN
Pathobiol Annu; 1981; 11():197-228. PubMed ID: 6276845
[No Abstract] [Full Text] [Related]
40. The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.
Craxì A; Di Marco V; Magrin S; Scalisi I; Vassallo R; Vinci M; Genova G; D'Amico G; Maisano S; Politi F
Prog Clin Biol Res; 1987; 234():153-65. PubMed ID: 3628374
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
